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Androgen receptor (AR) is a pivotal 
transcription factor in the develop-
ment of prostate cancer. In addition 
to male sex hormones, also post-
translational modifications can affect 
AR function and thus regulate the 
expression of androgen-responsive 
genes. This study proves that re-
versible modifications by a small 
ubiquitin-like modifier (SUMO) are 
important in the regulation of AR 
function in prostate cancer cells. The 
results may provide novel prospects 













































































































































































prostate cancer. Since the AR is a pivotal factor in prostate cancer, it represents a drug




SENP2, were potent in reversing AR SUMOylation in intact cells and in vitro. Based on
coexpressionandgenesilencinganalyses,SENP1actedalsoasaneffectiveARcoactivator.
However, gene expression analyses of cells stably expressing SUMOylated or
SUMOylationdefective AR demonstrated that the effect of receptor SUMOylation was
target gene selective. Diverse types of cell stress, including elevated temperature and
electrophilic stress evoked by the antiinflammatory prostaglandin, 15dPGJ2, induced a
rapidandmassiveconjugationofSUMOtotheAR.ThestresstriggeredSUMOylationwas
reversible,asARSUMOconjugateswerenolongerdetectedwhenthestresswasalleviated.
The cell stress had dynamic and reversible effects on the AR action as assessed by





defective AR showed retarded mobility in relation to the SUMOylated receptor as
measured by fluorescence recovery after photobleaching (FRAP) assays. These results
suggestthatSUMOylationisinvolvedinthemodulationofARmobilityandcyclingofthe




produced new information concerning AR kinetics in the nucleoplasm and the effect of
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välityksellä. AR:n kanssa vuorovaikuttavat koregulaattorit eli säätelyproteiinit,
kromatiinirakenne sekä proteiinien synteesin jälkeiset muokkausreaktiot,
proteiinimodifikaatiot, vaikuttavat myös geeniluennan aktiivisuuteen. Ubikitinaatio ja
fosforylaatio ovat esimerkkejä proteiinimodifikaatioista, jotka vaikuttavat AR:n
stabiilisuuteen ja aktiivisuuteen geeniluennassa. AR:n toiminta säätelee eturauhasen
normaaliakasvua sekäeturauhassyövänkehittymistä ja etenemistä,minkävuoksiARon
merkittävä lääkinnällisen terapian ja lääkekehitystyön kohde. Tämän väitöskirjatyön
tavoitteenaolitutkiaAR:nSUMO(smallubiquitinlikemodifier)modifikaatioitajaniiden
vaikutusta reseptorin toimintaan eturauhassyöpäsoluissa. AR:n havaittiin muodostavan
konjugaatteja enimmäkseen SUMO2/3:n kanssa, ja androgeenit lisäsivät SUMO
konjugaatiota, SUMOlaatiota. SENPentsyymit katalysoivat reaktion palautuvuutta.
SENP1 ja SENP2 entsyymien todettiin olevan tehokkaita vähentämään AR:n
SUMOlaatiota.Lisäksi nevoimistivatAR:n aktiivisuutta geeniluennan säätelijänä.Työssä
kuitenkin todettiin ARsäädeltyjen geenien olevan erilailla riippuvaisia reseptorin
SUMOlaatiosta.Solustressi,kutenkohonnutlämpötilajaprostaglandiini15dPGJ2,lisäsivät
nopeasti ja voimakkaasti AR:n SUMOmodifikaatiota. Solustressillä oli dynaamisia
vaikutuksia AR:n toimintaan, sillä solustressi esti AR:n sitoutumisen kromatiiniin ja
androgeenisäädeltyjen geenien ilmentymisen. Lisäksi stressitekijät muuttivat AR:n
tumansisäistäsijaintia.SolustressinvaikutuksetAR:iinolivatpalautuvia.SUMOmuokatun
AR:nhavaittiinliikkuvantumassanopeamminkuinSUMOlaatioonkyvyttömänreseptorin.
Tutkimuksen johtopäätöksenä todettiin, että SUMOlaatio vaikuttaa AR:n liikkumiseen
tumassa, millä taas on vaikutusta reseptorin aktiiviseen kierrätykseen geeniluennan eri
vaiheissa. Solustressin aiheuttama SUMOlaatio puolestaan vaikuttaa tärkeältä AR:n
liukoisuudenylläpitämisessä.TyössämyösosoitettiinSUMOmuokkaustensäätelynolevan
tärkeääeturauhassyöpäsolujenkasvunkannalta,silläSENP1geeninhiljentäminenvähensi
solukasvua. Tutkimus tuotti uutta tietoa AR:n tumansisäisestä kinetiikasta sekä sen
vaikutuksesta ARsäädeltyjen geenien aktiivisuuteen. Tutkimustuloksilla on merkitystä
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Androgen receptor (AR) is a hormoneactivated transcription factor that belongs to the
steroid receptor subclass of the  nuclear receptor superfamily. Androgens, male sex
hormones testosteroneand5dihydrotestosterone,arenaturalagonists for theAR.Once
the hormone binds to the AR in the cytosol, the receptor is released from chaperone
proteins, itsconformationchangesandthereceptorhormonecomplexenters thenucleus.
AR homodimers bind to chromatin at palindromic androgen response elements and
regulate expression of target genes. In addition to the basal transcription machinery,




their targets in a reversible manner. In addition to androgens, also PTMs regulate the
activity of AR. PTMs are dynamically adjusted according to the changes in the cellular
environment,suchascellstress.PTMscanaffectproteinstabilityandcellularlocalization.
Furthermore, they modify protein activity and the interactions occurring with other
proteins. In summary, PTMs confer wide variation onto protein structure and function.
PTMs can be small moleculemodifications, such as phosphorylation and acetylation, or
alternativelythemodifierscanbesmallproteins,likeubiquitinandSUMO(smallubiquitin
likemodifier).Itisnoteworthythattherearemanyfactors,suchaschromatinstructureand
coregulators, which play a role in ARdependent transcription, and these too can be
modifiedbyvariousPTMs.
The development and progression of prostate cancer is strongly dependent on AR
signaling. Thus, the receptor represents a significant drug target. Currently, AR
antagonists, antiandrogens, are being used in therapeutic protocols to restrict the AR
activityandpreventprogressionofthecancer.Unfortunately,hormonaltherapyoftenfails,
since the disease eventually converts into a castrationresistant stage, i.e. it no longer is
responsive to antihormones. Therefore, alternative approaches for AR inhibition are
needed.
The AR ismodified by SUMO,whichmodulates the transcriptional activity of the
receptor. Moreover, several components of the SUMOylation pathway function as
coregulatorsofARsignaling,andinterestingly, theseareoftenoverexpressedinprostate
cancer cells. Thus, SUMOylation pathway may appear as a potential target for medical
interventionto inhibitARfunction in theprostate tissue.Therefore, theformationofAR











2.1 ANDROGEN RECEPTOR 
Androgen receptor (AR) is expressed to some degree almost in every tissue, with the
highest expression level observed in the male reproductive organs and adrenal gland
(Kelleretal.1996).ThephysiologicalfunctionoftheARistomediatetheeffectsofthemale
hormones, i.e. androgens, to the level of the genes. Testosterone and its more potent
metabolite,5dihydrotestosterone(DHT),aretheendogenoushighaffinityligandsforthe
AR. Testosterone is a steroid hormone that is primarily synthesized from cholesterol in
Leydig cells in the testes. In addition, the adrenal glands and the ovaries synthesize




tissues, including prostate. Moreover, AR action is involved in the promotion and
maintenance of the male phenotype. Androgens are responsible for male sexual
differentiation,pubertalchanges,andspermatogenesis. IntheabsenceofARactivitymen
presenta testicular feminizationsyndromeandexpressa femalephenotype (Jääskeläinen
2012). The hormoneactivated AR acts also in brain and skin and participates in
maintainingboth themassandstrengthofmuscleandbone.Thus,a functionalAR isan
importantfactorinbothdevelopmentalanddifferentiationprocessesinhealthanddisease
(Matsumotoetal.2012).
Thegeneencoding thehumanAR is locatedon theXchromosome longarmand it
consists of eight exons that encode a protein of 919 amino acids.AR is amember of the
steroid receptor (SR) family within the broad nuclear receptor (NR) superfamily. AR is
structurally and functionally related to theother SRs, suchas theglucocorticoid receptor
(GR),mineralocorticoid receptor (MR),progesterone receptor (PR), andestrogen receptor
(ER)(Aranda&Pascual2001).Incommon,SRsaremodularinstructure,andtheyfunction
as hormoneactivated transcription factors (TFs) capable of regulating the expression of
complex gene networks. However, SRs exhibit several differences in their structural





1988). SRs proved to share many structural similarities, i.e. they are organized into
functional domains (Mangelsdorf et al. 1995, Huang et al. 2010). In general termes, AR
consistsoffourdistinctdomainslistedinorderfromtheaminoterminus(N)tothecarboxy











Figure 1. Domain structure of the full-length human AR (919 amino acids). N, the amino 
terminus; C, carboxy terminus; NTD, the amino-terminal domain; DBD, the DNA-binding 
domain; H, the hinge region; LBD, the ligand-binding domain, AF, activation function; TAU, 
transcription activation unit; PolyQ and PolyG, the polyglutamine and the polyglycine stretch, 
respectively; NLS, the nuclear localization signal; FxxLF and WxxLF, the motifs that are involved 







interaction surface for ARinteracting proteins. However, it shares only 20% sequence
similarity with PR, and thus, it is believed to contribute to the specificity of the steroid
hormone/receptor response (Gao et al. 2005).Moreover, the ARNTD is polymorphic in
itself,sinceitcontainsvariablepolyglutamine(polyQ)andpolyglycine(polyG)extensions.
Thus, the major difference between AR variants in different individuals lies within the
lengthoftheNTD.ThepolyQandpolyGrepeatsarecommonly936and1030residuesin
length, respectively (Palazzolo et al. 2008). An atypical extension of the polyQ tract has
beenfoundtoplayaroleintheneuromuscularKennedy’sdisease,wheretherepeatranges
from 40 to 52 residues. A naturally occurring 45kDa receptor isoform (AR45) has been
reported to exist as a splice variant of human AR (AhrensFath et al. 2005). The AR45
containstheentireARDBDandLBDandasevenaminoacidsequenceattheNterminusin
placeofthewildtypeARNTD.
TheARNTD contains the ligandindependent activation function1 (AF1) and it is
considered as the major activation domain of the AR that consists of two transcription
activation units, TAU1 and TAU5 (Jenster et al. 1995). TAU5 contains an LBD
independent activation potential, whereas TAU1 activity requires the presence of LBD.
Importantly, these TAUs interact with several coregulatory proteins. The NTD contains
highly conserved FxxLFlike motifs, 23FQNLF27 and 433WHTLF437 that mediate
interactionsbetweentheNTDandtheCterminalLBDofthereceptor(Heetal.1999,Heet
al.2000).Theandrogeninducedintramolecular interaction,termedtheN/Cinteraction, is
essential forAR function (Ikonen et al. 1997). Intriguingly, this kind of property has not
been identified in the other NRs (Schaufele et al. 2005). In summary, the variable and
relativelyunstructuredARNTDisanimportantregulatorydomainofthereceptor.TheAR
NTDhasbeenpostulatedtoserveasaflexibleplatformfortherecruitmentandassemblyof




In contrast to theNTD, theDBD iswell conserved inNRs (Helsenet al. 2012).The
DBD consists of two tandem cysteinerich zinc finger motifs, where one zinc ion
coordinatesfourcysteineresidueswithineachzincfingerstructure(Fig.2).Thefunctionof
















intracellular localization of the AR, DNAbinding, coregulator interactions, and receptor
foldingemphasizingtheimportanceoftheshorthingeregion(Haelensetal.2007,Tanner
et al. 2010). The AR hinge harbors a putative PEST sequence, i.e. a peptide sequence,




and the hinge region are encoded in different exons (exons 2, 3 and 4).A splice variant
namedAR23hasbeen found in specimens taken fromprostate cancer (PC)patients.The
misspliced receptor contains a 69bp insertion in the frame that creates a 23amino acid






Figure 2. Structure of the human AR DBD and a part of the hinge region. Amino acids 
comprising the P-box are in purple, D-box in green and the bipartite nuclear localization signal 






like interaction surface for coregulatory proteins. The surface is termed the ligand





the NTD to mediate the N/C interaction of the AR (Ikonen et al. 1997). As the AR is
transcriptionally inactive in the absence of androgen, the LBDmight actually inhibit the
strongligandindependentAF1activityoftheARNTD,andtherefore,suppressactivation
ofARtargetgenesintheabsenceofhormone(Brinkmannetal.1999).
The AR LBD binds natural androgens, synthetic androgens and different
antiandrogens.Ligandbindingoftenalters thecellulardistributionoftheAR(Fig.3).AR
ligands can be classified as agonists or antagonists based on their ability to activate or
inhibittranscriptionofARtargetgenes.Theclassificationcanalsobebasedonthestructure
oftheligand,andhence,namedassteroidalornonsteroidalhormones(Gaoetal.2005).
Several mutations have been found in the AR LBD (The Androgen Receptor Gene
MutationsDatabaseWorldWideWebServer,http://www.androgendb.mcgill.ca/).Almost
twothirdsofthemutationsaremissensesubstitutionsofsingleaminoacids.Thesekindsof
mutations in theLBDcommonlyaffectboth ligandbindingaffinityandspecificity.Thus,
many mutations of the LBD are associated with diseases, like PC and androgen







Figure 3. The effect of androgen on the cellular distribution of the AR as visualized by confocal 
microscopy. COS-1 cells transiently expressing enhanced green fluorescent protein (EGFP) 
tagged AR were treated with (+) synthetic R1881 or vehicle (-) for 1 h. Anti-lamin 
immunostaining depicts the nuclear envelope. The images were collected using Zeiss LSM 700 








the cell (Black et al. 2004, Shank& Paschal 2005,Marcelli et al. 2006). In the absence of
hormone,theapoARisincorporatedintoachaperone/immunophilincomplex,containing
e.g.heatshockprotein90(HSP90)andthereceptorislocalizedmainlyinthecytosol(Pratt
& Toft 1997). The androgenoccupied holoAR becomes concentrated in the nucleus.
Ligandbinding launches a cascadewhere the receptormonomer releases the chaperone
proteins,undergoesaconformationalchangeallowingtheARdimerize,andthedimerthen






Figure 4. A schematic presentation of AR signaling. SHBG, sex-hormone-binding globulin; DHT, 
dihydrotestosterone; AR, androgen receptor; HSP, heat-shock protein; P, phosphorylation; 
ARA70, an AR coregulator; GTA, general transcription apparatus; PSA, prostate-specific antigen. 
(Reprinted from Feldman & Feldman 2001 with permission of Nature Publishing Group.) 
 

Afternuclearentryof theholoAR, the receptor recognizesandbinds specificDNA
motifs, AREs, in a DBDdirected manner to start transcription of androgenresponsive
genes (Riegman et al. 1991).Classically, SRhomodimersbindheadtohead inhexameric
invertedrepeat (IR3) response elements 5’AGAACAnnnTGTTCT3’, where n represents
any nucleotide. However, AR dimers are also able to bind chromatin headtohead and
headtotail indirectrepeat (DR3)elements5’AGAACAnnnAGAACA3’ (Claessensetal.
2001, Shaffer et al. 2004, Denayer et al. 2010). Multiple AREs are often found in the
regulatoryregionsofARtargetgenes,andtheelementsdisplaycooperativityinenhancing






noteworthy that the bestcharacterized androgenregulated genes are not regulated by
perfectAREs(Dehm&Tindall2007),suggestingthatARDNAbindingpropertiesmaybe
highlyadjustable.ARbindingonsomegenesdependsonthesurroundingbindingsitesfor
the other cellspecific TFs such as themembers of the Forkhead, GATAbinding protein




families (Heemers & Tindall 2007,Wang et al. 2007). For instance, the forkhead box A1
protein (FOXA1; alsoHNF3, hepatocyte nuclear factor 3)may act as a pioneering or
licenzingfactorforARbinding.FOXA1mayparticipateinARtargetgenerecognition,orit
maymaskARbindingsites(Gaoetal.2003,Sahuetal.2011).Recentgenomewidestudies
(chromatin immunoprecipitation followed by DNA sequencing, ChIPseq) have proved
that most of the ARbinding sites are located on distal enhancers, far away from the
transcriptionstartsites(Wuetal.2011).
Thebiological functionof theARandandrogens is toalter expressionofAR target
genes. Gene productswhich are expressed in anARdependentmanner are involved in
severalcellularfunctionsincludingcellsurvival,inductionofproliferationandsuppression
ofapoptosis(Lamont&Tindall2010).Moreover,ARisinvolvedintheregulationofsteroid
biosynthesisandfattyacidmetabolism(Nganetal.2009). Inaddition to theactivationof
transcription, theAR isalsocapableofevokingrepression (Grosseetal.2012).However,
ARregulated repression of transcription has not been so extensively studied as theAR
activatedprocesses.The repressingeffectof theAR isnotmediated solelyviadirectAR
binding to chromatin. Instead, it is believed that the AR can interact with another
transcriptionfactor,suchasactivatorprotein1(AP1),thatisindirectcontactwithDNA






is controlledby coregulators that are alsooften called cofactors (Heinlein&Chang2004,
Rosenfeld et al. 2006, OMalley 2008). Basically, a coregulator is defined as a factor that




and the basal transcriptional machinery, and thus interfere with chromatin remodeling.
Importantly, the primary event in ARdirected transcription in the nucleus is the
modulation of local chromatin, since the chromatin structure is a principal factor that
controls the activity of gene expression. Therefore, tightly packed chromatin has to be
loosenedbymechanismsthatalterthearrangementofnucleosomesandcovalentlymodify
nucleosomalhistones.Noncovalentmodulationof nucleosome arrangement requires the
presence of chromatin remodeling complexes, such as switch mating type/sucrose non
fermenting (SWI/SNF), that consist of multiple subunits. Furthermore, covalent
modifications of the Nterminal histone tails (also termed histone marks) participate in
regulating the access of transcriptional initiators to chromatin (Kouzarides 2007). For
instance, acetylation of histones has long been known to loosen chromatin packing. The
acetylationiscatalysedbyhistoneacetylases(HATs)andhistonedeacetylases(HDACs).In
addition, methylation is an important modification of histones, which is regulated by
methyltransferasesanddemethylases(Heemers&Tindall2007).
AR coregulators have often been identified by yeasttwohybrid screens as direct
interactionpartnersofthereceptor(Jänneetal.2000,vandeWijngaartetal.2012).TheAR
interacting coregulators play major roles during the ARdependent gene transcription,
since they can influence a number of functional properties of the receptor, including its
ligandbinding selectivity and DNAbinding capacity. In contrast to the other NRs, the
coactivators involved in transcriptional activation of the AR are recruited into different
regions in the AR NTD and the hinge region (Heemers & Tindall 2007). Ligand
independentAF1intheARNTDisthemajorinteractionsurfaceforARcoregulators,asit





motif with the AF2 in the AR LBD (He et al. 2002). There are many important AR
coregulators e.g. p160family members, steroid receptor coactivators 13 (SRC13; also
transcriptional intermediary factors13,TIF13).They facilitate therecruitmentofhistone
modifingenzymessuchasp300,cAMPresponseelementbindingprotein(CREB)binding
protein (CBP), p300/CBPassociated factor (P/CAF), and coactivatorassociated arginine
methyltransferase 1 (CARM1) (Heemers & Tindall 2007). In addition to chromatin
modulatingprocesses and interactionswith coactivators listed as examples above, also a
multisubunit bridging factor, termed theMediator complex, between the AR and RNA
polymeraseIImachineryisinvolvedinthetranscriptionalactivationoftheAR.
Since transcription is awell controlledmultistepevent, transcriptional corepressors
worktosuppresstheprocess.AntiandrogenbindingtotheARLBDdirectsthehelix12toa
position different from that involved in the agonistbound receptor recruiting
transcriptional corepressors (Gao et al. 2005). Nuclear corepressor 1 (NCoR1), silencing






2.2 POST-TRANSLATIONAL MODIFICATIONS OF THE AR 
The human genome comprises 20000 genes encoding the synthesis of proteins that are
important structural components of cells orwhich function as biologically active factors,
such as enzymes and transcriptional regulators. Posttranslational modifications (PTMs)
providehugeopportunitiesfortheregulationofthepropertiesoftheseproteins.ThePTMs
are also involved in the transcriptional activity of AR (Anbalagan et al. 2012, Coffey &
Robson 2012, Gioeli & Paschal 2012). PTMs can be roughly divided into two categories:
smallmoleculemodifiers,suchasphosphate(phosphorylation),acetyl(acetylation),methyl
(methylation), nitric oxide (nitrosylation), andmodifiers that are proteins in themselves,
like ubiquitin (ubiquitylation) and ubiquitinlike modifiers (e.g. SUMOylation,
NEDDylation, ISGylation). Moreover, protein structures can also be modulated by
conjugationwith carbohydrates (glycosylation) andbyADP ribosylation. PTMsplaykey












Haendler 2006).Hormonebindingaffects thekineticsofdiversePTMs targeting theSRs.
Notonlyhormones,butalsoPTMsarelikelytoregulatethetranscriptionalactivityofSRs,
includingtheAR.Thus,thereceptor,aswellastranscriptionalcoregulatorsandchromatin







Figure 5. Major sites for PTMs in the human AR: A linear presentation of the AR polypeptide, 
where lysine modifications (SUMOylation, ubiquitylation, acetylation, methylation) and 
phosphorylation sites are depicted above and below the functional domains of the receptor, 
respectively. The numbering is based on the accession number P10275 in National Center for 









of the AR phosphorylation sites (phosphosites) are serine residues (12 of 17), but also
threonine(2of17)andtyrosine(3of17)residuesareputativephosphositesofAR.Mostof
theARphosphositesresideintheNTD.Furthermore,phosphositesarealsolocatedinother
functional domains: S578 in theDBD, S650 in the hinge, and S791 andT850 in theLDB.
Typically, androgens induce phosphorylation of theAR. The phosphorylatedAR can be
detectedasaslightlyslowermigratingbandsinimmunoblotanalysis(vanLaaretal.1990,
Kuiperetal.1991).PhosphospecificantiARantibodieshavealsobeengenerated(Gioeliet
al. 2006). In addition to androgeninduced modification, constitutively phosphorylated
sites, suchasS94,havebeen identified (Gioeli etal. 2002). Inaddition toandrogens,also
growth factors are able to induce phosphorylation of the AR. For instance, epidermal
growth factor (EGF) signaling leads to activation of several downstream kinases and
increasedphosphorylationoftheAR(Gioelietal.2002,Guoetal.2006,Pongutaetal.2008).
Phosphorylation is a reversible reaction: kinases phosphorylate proteins and
phosphatasesreversethismodification.Generally,androgenbindingisthoughttoinducea
conformationalchangeinthereceptor,whichrendersthephosphositesmoreaccessibleto
the kinases. Alternatively, in the absence of androgen, the phosphosites may be well
available to kinases, but androgenbinding can impair phosphatase interactions, which
resultsinincreasedphosphorylationoftheAR(Yangetal.2007).Overall,thelocalizationof
theARisamajordeterminantofitsphosphorylationstate.ItisknownthattheARshuttles
between cytoplasmic and nuclear compartments, and ARtargeting kinases and
phosphatasesarelikelytobeenrichedindifferentcellularlocalisations.AstudyusingAR



















Acetylation was initially found to enhance AR transcription, since the HDAC inhibitor
trichostatin A (TSA) increased the expression of AR target genes (List et al. 1999).
Thereafter, the lysine(K)residueswithinthemotif630KLKK633intheARhingeregion
havebeenidentifiedasdirectacetylationtargetsitesinthereceptor.Inaddition,theacetyl
moiety can also be attached to the side chain of arginine (R).However, in theAR, only
acetylationof lysinehas beendescribed. Interestingly, the lysinerich acetylationmotif is
conserved with different TFs, including NRs and the tumor suppressor p53 (Sterner &
Berger2000).Acetyltransferasesp300/CBP,Tatinteractingprotein60kDa (TIP60) andN
acetyltransferase arrestdefect 1protein (ARD1)acetylate theARand increase its activity
(Fuetal.2000,Gaughanetal.2002,WangZ.etal.2012).
In addition to processing histones, HDAC1 deacetylates AR and suppresses AR




its coregulators. The AR acetylation sites modulate transcription in a promoterselective
manner,providingfinetuningeffectsontheexpressionofdifferentARtargetgenes(Faus
&Haendler2008).Asaconsequence,acetylationofNRs,includingtheAR,affectscellular
growth and apoptosis, biological functions that are typically dysregulated in cancer.




Methylation has been known to modulate NRregulated transcription, because several
componentsof chromatin, i.e.histonesandcytosinenucleotides inDNA,aremethylated.
Interestingly, methylation of the AR has only recently been discovered (Gaughan et al.
2011,Koetal.2011).Likeacetylation,methylationcanoccuratlysineorarginineresidues,
but onlyK630 andK632 in theARhave been proposed to be putativemethylation sites
(Gaughanetal.2011,Koetal.2011).TheARhingeregioncontainsamotif(namedaboveas















histone marks. LSD1 has been found to be upregulated in high grade prostate tumors
(Metzgeretal.2005,Kahletal.2006).However,itremainstobedetermined,whetherLSD1
candirectlydemethylatetheAR.SincemethylationisthemostrecentlyfoundPTMofthe




Proteinmodificationbyubiquitin is a similarly reversiblePTMas thosediscussedabove.
However,themajordifferenceisthatthemodifierisasmallproteinitself;a76aminoacid
polypeptide binds via a covalent isopeptide bond to the amino group of a lysine in a
substrate.Thisisabulkymodification,sinceubiquitinisalsoabletoformbothlinearand
branched polymers. Conjugation of ubiquitin, ubiquitylation, is a threestep enzymatic
cascade requiring specific enzymatic activities: E1 activation  E2 conjugation  E3
ligation.Human cells express two different E1 enzymes, ~30 and over 300 E2s and E3s,
respectively (Bergink & Jentsch 2009). First, an E1 ubiquitin activating enzyme binds
ubiquitin,consumingenergyfromATP.Then,theE1boundubiquitinistransferredtoan
E2conjugatingenzyme.Finally,anE3ubiquitinligasetransfersubiquitinfromtheE2tothe






proteins to proteasomal degradation (Ciechanover et al. 1980, Hershko et al. 1980). The
significanceofthefindingculminatedintheawardoftheNobelPrizeinchemistryin2004.
Histone H2 was the first protein identified to form ubiquitin conjugates (Goldknopf &
Busch1977,Hunt&Dayhoff1977).DynamicmonoubiquitylationofH2AandH2Bhasbeen
found to regulate chromatin structure and recruitment of transcriptional coregulators
(Weake&Workman2008).Ubiquitinproteasomesystem(UPS)participates incontrolling
gene regulatory mechanisms, and importantly, both proteolytic and nonproteolytic
activities are involved (Geng et al. 2012, HammondMartel et al. 2012). Nonproteolytic
ubiquitylation can regulate TF binding with chromatin and coregulators, whereas
proteolytic ubiquitylation modulates functional activity of TFs, e.g. by facilitating the
turnoverofaparticularTFonchromatin(Reidetal.2003,LeCametal.2006).
Thedivergentoutcomeofubiquitinconjugationislikelytoarisefromtheabilityofthe
modifier to conjugate target lysines as monoubiquitin or to form polymers. All seven
conserved lysine residues within the ubiquitin can mediate the formation of ubiquitin
polymers (Kim H.T. et al. 2007). Interestingly, each type of linear or branching chains
conjugated at different lysine residues in the substratehave their owndistinct biological
effects.Forinstance,theK48branchedpolyubiquitinchainsfunctionclassicallyastagsfor




SRs are degraded via conjugation of polyubiquitin, and the ubiquitin pathway is
knowntoregulateSRaction,includingtheARactivity(Nawaz&OMalley2004,Kinyamu
et al. 2005, Alarid 2006). However, the components of the ubiquitylation machinery
responsible for transferring ubiquitin to the AR and the sites of ubiquitylation in the
receptor have not yet been definitely established. The ubiquitin E3 ligases the mouse
doubleminute2homolog(MDM2)andthecarboxyterminusofHSP70interactingprotein






protein 6 (RNF6) that is overexpressed in castrationresistant PC, has been reported to
mediate K6/K27linked ubiquitylation to these AR sites promoting the transcriptional
activityofthereceptor.ARubiquitylationbymixedbranchingchainshasbeensuggestedto
functionasascaffoldingfactorpromotingtherecruitmentofcoactivators(Xuetal.2009).In
addition, theubiquitinE2 conjugating enzyme,UBCH7, functions as a coactivator of the
AR and several other SRs in a conjugating activitydependent manner, probably
modulating the exchange of coactivator complexes (Verma et al. 2004). In addition,
ubiquitinproteaseUSP10canfunctionasacoactivatoroftheAR,eventhoughitsroleinthe
regulation of ARubiquitin conjugates is not fully clarified (Faus et al. 2005). Moreover,












conjugates may be difficult to detect. SUMO was identified in 1996 in a variety of
independent studies, explaining why it also appears as sentrin, PIC1 and UBL1 in the
literature(Boddyetal.1996,Okuraetal.1996,Matunisetal.1996,Shenetal.1996,Mahajan
et al. 1997). Subsequently increasing number of proteins have been identified as SUMO
substrates particularly due to advancedmass spectrometric methods (Gocke et al. 2005,
RosasAcosta et al. 2005, Vertegaal et al. 2006, Matic et al. 2010, Tatham et al. 2011).
FunctionalcategoriesofSUMOylatedproteinsincludeTFs,DNArepairandstressrelated
proteins, and a variety of metabolic enzymes. Thus, the modification affects many
important cellular processes including the control of genomic stability and signal











ARwas theveryfirstSR identifiedasa target forSUMOconjugation(Poukkaetal.
2000a).Asdiscussedabove,theNTDisthemostvariabledomainamongSRs,andtheAF1
sequenceoftheARshowsweakconservation(<15%)acrosstheSRfamily.Despitethis,the
SUMOylation sites are highly conserved in the NTDs of SRs, pointing to an important
functionforSUMOmodification.TheSUMOylationsitesoftheAR,thelysines386and520,
arelocatedwithintheligandindependenttransactivationdomain.SUMOylationhasbeen
often linked to transrepression. For example, the SUMOylationdeficient AR is






suggested to be involved in the suppression of SUMOylated TFs (Stielow et al. 2008,
Ouyang & Gill 2009, Ouyang et al. 2009). It is significant that SUMOylation regulates
transcriptionnotonlybytargetingDNAbindingofTFs,butitalsomodifiescoregulatory







sequences differ significantly from ubiquitin. For example, SUMO1 shares only ~18%
amino acid homology with ubiquitin. Furthermore, SUMO2 and SUMO3 are almost
identicalwitheachother,whereastheyshare~50%sequencehomologywithSUMO1.The
endogenous expression of SUMOs also differs. SUMO1, 2 and 3 are ubiquitously






Themajor difference betweenSUMO2 and 3 is theCterminal fragment that is cleaved
during the maturation/conjugation process (Fig. 6). These SUMO paralogs cannot be
distinguishedbythecurrentlyavailableantibodiesandhencearedescribedintheliterature
as SUMO2/3. The SUMO4 isoform has been suggested to be incapable of performing
conjugation,since theCterminalprolineresidueproximal to thedoubleglycineprevents
theactionSENP(Owerbachetal.2005).AfterSUMOmaturation,aheterodimerofSUMO
activatingenzyme1and2 (SAE1/SAE2)contacts theCterminal carboxygroupofSUMO
via a thioester bond (Gong et al. 1999). Activated SUMO is further transferred to the
catalyticcysteineresidueofSUMOconjugatingenzyme9(UBC9)thatprovidesSUMOsto
thetargetsitesinthesubstrateproteins(Desterroetal.1997,Gongetal.1997,Sampsonet
al. 2001). Finally, a ligation step ismediated by a limitednumber of SUMO ligases (E3),
suchasRanBP2,polycompprotein2(Pc2)andproteininhibitorofactivatedSTATs(signal
transducer and activator of transcription) proteins (PIAS).Endogenous SUMOE3 ligases
arelikelytofunctionasenhancersoftheconjugationprocessbyregulatingtheinteractions
betweensubstrateproteins,SUMOandUBC9(Kotajaetal.2002b,Pichleretal.2002,Kagey
et al. 2003). The SUMO E3 ligases may also play a role in SUMOparalog selective
modifications.StructuralanalyseshaverevealedthatRanBP2formsamorestablecomplex







Figure 6. Reversible SUMO modification pathway. The upper part of the figure depicts the 
double glycine maturation site of human SUMOs. 
 
 
SUMOacceptor lysines in targetproteinsareoften,also in theAR, locatedwithina
consensus sequence	KXE/D,where	 is a hydrophobic aminoacid (leucine, isoleucine,
valine)andXisanyaminoacidfollowedbyanacidicaminoacid.Anisopeptidebondis
formed between the Cterminal glycine of SUMO and the amino group of lysine. A






chain terminating the polymerization (Matic et al. 2008). SUMO2/3 conjugation, but not
SUMO1, has been shown to be increasedduring cellular stress (Saitoh&Hinchey 2000,
Vertegaaletal.2006).Ubiquitinformsbranchedpolymericchains,butsuchpropertiesare
notreportedforSUMOs,eventhoughthereareelevenandeightlysineresiduesintotalin
SUMO1 and SUMO2/3, respectively. Proteins can be modified in a SUMO paralog
selectivemanner.ThechargeofthesurroundingaminoacidsclosetotheSUMOconsensus
motif and SUMO E3 ligases are believed to function as specificity factors (Tatham et al.
2005,Yangetal.2006,Maticetal.2010).
Distinctfromtheubiquitinpathway,humancellsexpressmerelyoneSUMOE1and
SUMO E2 enzymes, and at present only a limited number of SUMO E3s have been
identified. The physiological significance ofUBC9 and intact SUMOylation pathway has
been demonstrated with Ubc9 knockout mice, as the deletion is embryonally lethal
(Nacerddineetal.2005).Themammalian familyofPIASproteins includes fivemembers:
PIAS1, PIAS3, PIAS4 (also PIASy), PIASx (also ARIP3, androgen receptor interacting
protein 3), and PIASx







because PIAS family members may substitute for each other’s functions. In contrast,





However, today, in addition to cytokine signaling, PIAS proteins are emerging as
important regulators of many cellular functions, including ARdependent transcription.







both proteinprotein interactions and proteinDNA interactions. PIAS proteins enhance
SUMOylation via a cysteine rich Siz/PIAS RING (SPRING) domain. In addition, PIAS
proteinsharboraconservedSUMOinteractingmotif(SIM)thatisahydrophobicmotifrich
invalineandisoleucineresidues,interactingwithcovalentlyconjugatedSUMOs(Kerscher
2007, Rytinki et al. 2009). SIMs and SUMOylation seem tomediate interaction networks
betweencellularproteins.InadditiontoPIASproteins,alsootherARcoregulatorscontain
SIMs (Moilanen et al. 1998a,Moilanen et al. 1998b, Tatham et al. 2008, de laVega et al.





SUMO modification is a dynamic and reversible reaction. Deconjugation of SUMOs is
catalyzedbySUMOspecificproteases (SENPs) (Mukhopadhyay&Dasso2007,Yeh2009,
Kollietal.2010).Additionally,anewly identifiedDeSumoylatingIsopeptidase1 (DeSI1)
has been postulated to form a second class of SUMO proteases (Shin et al. 2012).
MammaliangenomeencodessixSENPenzymes:SENP1, 2, 3, 5, 6,and 7.TheSENPs
belong to the family of cysteine proteases sharing conserved Cterminal domains. In
contrast, the Nterminal domains of SENPs vary in size and sequence and show no












maturation and deconjugation of different SUMO paralogs. Accordingly, SENPs can be
classified intothreegroups: (i)SENP1and2shownopreferences inprocessingdifferent
SUMO paralogs and they also are involved in the deconjugation of all SUMO paralogs
(Gongetal.2000,Hang&Dasso2002,Zhangetal.2002).(ii)SENP3and5favourclearly
SUMO2/3overSUMO1(Nishidaetal.2000,DiBaccoetal.2006,Gong&Yeh2006).(iii)










Table 1. Summary of SENP characteristics. 
 






























nuclear pore nucleolus nucleolus nucleoplasm nucleoplasm 
High expression 
 


































of human PC (Cheng et al. 2006). The altered expression of different SENPs has been
observed also in several other carcinomas: SENP1 in thyroid oncocytic adenocarcinoma
(Jacquesetal.2005),SENP3inprostate,ovarian,lung,rectum,andcoloncarcinomas(Han
et al. 2010), and SENP6 in breast tumor tissue (Mooney et al. 2010). Furthermore,









that SENPs are intrinsically heatsensitive and this property emerges from the catalytic
domainsofSENPs.Thus, itmaybepossible thatcatalyticcysteineresidues in theSENPs
participatealsoinsensingfunctions,e.g.responsestooxidativestress.Ontheotherhand,
SENP3protein levelshavebeenreportedtobe inducedbyreactiveoxygenspecies (ROS)
(Huangetal.2009).Duetotheirderegulationindifferentcancers,SENPsareconsideredas








PTMs have mostly been studied as individual events. The interplay between different
modifications inmultiple signalingpathways is emerging (Seet et al. 2006).Asdiscussed
above,differentlysinemodificationsoftheARseemtobeenrichedindifferentfunctional
domains of the receptor: SUMOylation in the NTD, acetylation and methylation in the
hinge domain, and ubiquitylation in the LBD (Fig. 5). However, different PTMs are not
likely to function in isolation, but rather there is crosstalk with each other establishing
molecular diversity. For instance, phosphorylation can modify serine/threonine/tyrosine
residuesalong thewholepolypeptide inanandrogenenhancedmanner.Androgensalso
enable receptor folding and promote the N/C interaction, which places the sites for
different PTMs and their enzymatic machineries in close proximity with each other.
Therefore, the biological threedimensional structure is far more complex than can be




Thehinge region in theAR is the shortestdomain. In relation to its size, thehinge
mightbe themostheavilymodifieddomainof the receptor, as the lysine residues in the
hinge are in principle targets for both acetylation and methylation. Thus, these PTMs
would seem to be themost obviousmodifications to occur in a sequential order as they
target the same sites in the AR. However, it has not been reported whether these two
modificationscompete for thesame lysineandwhether theyareregulated inconjunction
witheachother.AndrogeninducedARacetylationbyTIP60hasbeenlinkedtothenuclear
importof the receptor (Shiota et al. 2010). Since thenucleus is rich inmethyltransferases




thereafter degraded in the proteasomes, but the exact site for conjugation of the
polyubiquitin has not been identified. Akt (also protein kinase B, PKB) and provirus
integrationsiteforMoloneymurineleukemiavirus1(PIM1)kinaseshavebeenshownto
enhanceserinephosphorylationoftheAR,increasingtheturnoverrateofthereceptorvia
the recruitment of MDM2 (Lin et al. 2002b, Linn et al. 2012). Furthermore, Linn and
coworkers(2012)suggestedthatanotherPIM1isoformwasalsocapableofmodifingT850,
which in turn recruited the ubiquitin E3 ligase RNF6 resulting in stabilization of the
receptor.BothstudiessuggestedthattheS213phosphorylationintheARisimportantfor





towards ubiquitylation by MDM2 (Chymkowitch et al. 2011). Here too, there is a
neighboringlysineresiduepresentclosetotheproposedphosphosite,andinterestingly,the
K520 has been identified as a SUMO consensus site in the AR (Poukka et al. 2000a).
However,itisnoteworthythatthetargetsitesfordifferentPTMsdonotneedtobeadjacent
inordertoorchestratetheregulationofthesamesubstrate.
Phosphorylation has been linked to SUMOylation in several studies. It may either
induce conjugation of SUMO or inhibit SUMOylation machinery to interact with the
substrate. Hietakangas and coworkers identified a phosphorylationdependent
SUMOylation motif (PDSM) that is present in several TFs and their coregulators
(Hietakangasetal.2006).However,concominantphosphorylationandSUMOylationofthe





nuclear RING finger protein, SNURF) as a SUMOtargeted ubiquitin ligase (STUbL) has
stimulated research interest in studying concomitant SUMOylation and ubiquitylation
(Praefckeetal.2012).RNF4isaubiquitinE3ligasethatrecognizesSUMOmoietiesviaSIMs
andsubsequentlypolyubiquitinates theSUMOylatedsubstrate (LallemandBreitenbachet
al. 2008, Tatham et al. 2008). RNF4 was originally identified as an ARinteracting
coactivator (Moilanen et al. 1998b), but it has not been reported to polyubiquitylateAR
SUMOconjugates.





SIMdependent interactions are promoted by the phosphorylation of an extended SIM
module (Stehmeier & Müller 2009). On the other hand, proteinprotein interactions
mediated by interactions between SUMOand SIM canbe impaired by acetylation of the




to alterations in the cellular environment, such as cellular stress (Deribe et al. 2010).
OxidativestresshasbeenreportedtomodulatetheSUMOylation/acetylationswitchofthe
homeodomaininteracting protein kinase 2 (HIPK2) (de laVega et al. 2012).HIPK3 (also
androgen receptorinteractingnuclearproteinkinase,ANPK) is a serine/threoninekinase
familymemberofHIPK2whichactsasanARcoactivatorwithoutdirectlyphosphorylating
theAR(Moilanenetal.1998a).HIPK1,2and3containaconservedCterminalSIMthat
colocalizeswith theAR interactiondomain found inHIPK3 (Moilanenet al. 1998a,de la
Vega et al. 2011). In addition, similarly to HIPK2, HIPK3 contains a consensus
SUMOylation motif in the Nterminal domain preceding the kinase domain. However,
SUMOylationofHIPK3hasnotbeenreported.Itmaybepossiblethatthesehomeodomain
interactingproteins canmodulateARaction in a SUMOylationmediatedmannerduring
cell stress. In conclusion, dynamic PTMs are likely to optimize the activity of many
biological processes, including ARregulated gene expression, to guarantee the
maintenanceofcellularhomeostasis.

2.3   PROSTATE CANCER 
Prostatehyperplasiaisacommonbenigndisorderinelderlymenanditcantransforminto
invasive cancer. However, the development of prostate cancer (PC), which is the most
prevalentcarcinomaamongwesternmen, isnotalwayseitheragerelatedorprecededby
hyperplasia. The linkage of PC to advanced age presumably reflects the interplay of




consequence of oxidative stress, which has a cumulative impact on DNA damage
(Khandrikaetal.2009,Minelli etal.2009).Theapplicationofnextgenerationsequencing
methodshasdemonstratedaspectrumofDNAalterationsinadvancedPC.Inparticular,a
high incidence of genomic alterations occurs in key genes important for DNA repair




biological complexity. For instance, PC exhibits many phenotypical attributes,
morphological heterogeneity and substantial changes in its genetic makeup both within






The systemic structure of cancer has been described by Hanahan & Weinberg (2011).
Briefly, the development and progression of cancer is due to selfsufficience in growth






vets erythroblastosis virus E26 oncogene homolog (TMPRSS2ERG) gene fusions,
contributetoenhancedgrowthofPCcellsbypromotingtheexpressionofanoncogenein
an AR/androgendependent manner (Tomlins et al. 2005, KumarSinha et al. 2008).
Inhibition of the AR remains the key target in the treatment of advanced PC, and
suppression of the AR also holds great potential for preventing the development or
progression of early stage PC. Since the 1940s, endocrine therapy of prostate cancer has
beendirectedtowardthereductionofcirculatingandrogensandconsequentlyinhibitionof
AR transcriptional activity. Surgical or medical castration often supplemented with
antiandrogen treatment is a common therapeutic strategy. After hormone deprivation
therapy, however, the disease turns into a castrationresistant prostate cancer (CRPC),
which is amajor clinical challenge. InCRPC, the cancer cellshavenoneed for testicular




include the development of AR hypersensitive to low concentrations of circulating
androgens, mutations in the AR leading to altered ligandbinding and coregulator
interactionsorreceptoractivationwithoutandrogens.Inaddition,activationofalternative
survival pathways may be involved.  Latestage hormoneindependent PC almost
invariably retains the expression of the AR, despite the near absence of circulating
androgens (Hobisch et al. 1995). Furthermore, an amplification of theAR gene has been
commonlyidentifiedinCRPC(Visakorpietal.1995,Koivistoetal.1997,Linjaetal.2001).




In addition to altered AR expression, AR mutations are common findings in PC
patients. Altered AR splicing patterns have been proposed as a mechanism of prostate
carcinogenesisandresistancetoandrogenablationtherapy(Dehm&Tindall2011,Haile&
Sadar2011).Forinstance,theARLBDisoformfrequentlyexpressedinPCcontainsintact
NTD and DBD, but lacks ligandbinding ability. The LBDtruncated AR isoform is
constitutively nuclear and binds DNA in a manner which is independent of androgens
(Tepperetal.2002,Libertinietal.2007).Furthermore,singleaminoacidsubstitutionsinthe
ARareassociatedwiththeriskofPC.Forinstance,thereplacementofthreonine877with





by binding to other steroids such as cortisol, and even in the response to antiandrogens
which start to promote PC cell growth (Taplin et al. 1999, Zhao et al. 2000). Similarly, a






overexpression of SRCfamily members SRC1 and SRC2 (also glucocorticoid receptor
interacting protein 1, GRIP1) have been detected by immunohistochemical analysis
(Gregoryetal.2001a). Interestingly,GRIP1isahighlySUMOylatedcoactivatoroftheAR
(Kotaja et al. 2002a, Kotaja et al. 2002c). Altered expression of SUMOylation pathway
componentshavealsobeenfoundinPC.DecreasedexpressionofPIAS1maybeinvolved
in the progression of PC, as the amount of PIAS1 mRNA was significantly lower in
castrationresistantprostatetumorsthaninuntreatedtumors(Linjaetal.2004).Inanother
study,PIAS1proteinlevelshavebeenreportedtobesignificantlyhigherinmalignantareas
of clinical PC specimens than in normal tissues,whichmay enhance proliferation of PC
cellsthroughinhibitionofp21(Hoeferetal.2012).Moreover,overexpressionofSENP1has
beendetected in bothprecancerousprostate lesions andPC tissue samples (Cheng et al.
2006).Arecentstudyby thesameresearchers further indicated thatSENP1promotesPC
progressionandmetastasisviaregulationofhypoxiainduciblefactor1(HIF1)induced
expressionofmatrixmetalloproteinase2and9(MMP2and9)(WangQ.etal.2012).Thus,
components of the SUMOylation pathway may contribute to the proliferation of cancer
cellsandtumorinvasiveness.
Eventhoughprostatecarcinogenesismaybeindependentofcirculatingandrogens,it
isnot independentof theAR.TheAR is involved in all stagesofprostate tumorigenesis
includinginitiation,progression,andtreatmentresistance.Therefore,theARisasignificant
drug target for the development of novel therapeutics to the disease. Conceivable
approaches torestrictPCprogressionby inhibitionof theAR include,notonlyandrogen
ablation,butalsorestrainofARlevels,increasingnuclearexportoftheAR,andinhibition
of chromatin binding of the holoAR. Glucocorticoids have been provided to CRPC
patients, because these agents inhibit AR expression by repressing the action of nuclear
factorkappalightchainenhancerofactivatedBcells(NFkB)thatenhancesARexpression
and the growth of PC cells (Zhang et al. 2009). In addition, glucocorticoids are able to
decreaseadrenalandrogenproduction(Fakihetal.2002,Kassi&Moutsatsou2011).Today,
androgen biosynthesis can be effectively inhibited by abiraterone that functions as an
inhibitorof thecytochromeP450familymemberCYP17A1(Attardetal.2009,Steinetal.
2012).Cyproteroneacetatewasthefirstantiandrogenidentified.Itissteroidalinstructure
and functions as a competitive AR antagonist similar to nonsteroidal compounds
flutamide and bicalutamide. Modern types of antiandrogens, RD162 and MDV3100
(enzalutamide), impair AR interactions with coregulators and chromatin but also the
nuclearimportofthereceptor/ligandcomplex(Tranetal.2009,Scheretal.2010,Haendler
&Cleve 2012).Therapies that target theARLBDhaveno effects on constitutively active
splice variants of the AR, which are often Cterminally truncated. Therefore, small
molecule inhibitors that bind to the AR NTD have been developed, such as EPI001
(Andersenetal.2010).Inaddition,thereisongoingdevelopmentoftheARligandswith
tissueselective effects, which are classified as specific androgen receptor modulators






















effect of SUMOylation on the AR activity. Here, the major aims were to analyze





 To uncover cellular signals that affect SUMO modifications of the AR,
particularlytheendogenousARinPCcells.
















Awiderangeofcellandmolecularbiologymethodswasutilized in this thesis (Table2).





Table 2. Summary of the methods used in this thesis. 
 




I, II, III 
Construction of plasmids and site-directed mutagenesis I, II 
Transient transfection assays I, II, III 
Immunoprecipitation I, II, III 
Immunoblotting I, II, III 
Biotin pull down assay III 
In vitro SUMOylation and deSUMOylation assays I 
Reporter gene assays I, III 
Isolation of RNA I, II, III 
Quantitative RT-PCR I, II, III 
RNA interference I 
Immunofluorescence and confocal microscopy I, II, III 
Fluorescence recovery after photobleaching (FRAP) II 
Chromatin immunoprecipitation (ChIP) I, II, III 
Electrophoretic mobility shift assay (EMSA) III 
Cell proliferation assay I 








5.1   SUMO PARALOG-SELECTIVE MODIFICATIONS OF THE AR 
Human cells express three SUMO isoforms capable of conjugation to target proteins:
SUMO1and thenearly identical formsSUMO2and 3,whicharecollectivelynamedas
SUMO2/3.ARhasbeenpreviouslyshowntobemodifiedbySUMO1(Poukkaetal.2000a),
but the formationofARSUMO1andARSUMO2/3hasnotbeen comparedpreviously.
Fig. 1A in original article I illustrates that transiently expressed AR was modified in a
SUMOparalogselectivemannerbyectopicallyexpressedSUMOsinCOS1cells:ARwas
modified to a greater extent by SUMO1 than SUMO2. However, when the relative
expressionoftheendogenousSUMOswasstudied,itwasfoundthatSUMO2/3wasmore
abundant than SUMO1 in the AR positive vertebralcancer of the prostate (VCaP) cells
(AppendixFig.A1inII).AsimilarSUMOexpressionpatternhasbeenobservedindifferent
mouse tissues (Zhangetal. 2008).EndogenousSUMOylationof theARwasanalyzedby
coimmunoprecipitation assays with antiAR antibody followed by subsequent
immunoblotting against SUMOs. Interestingly, ARSUMO2/3 conjugates dominated in
VCaP cells (Fig. 1A in II). SUMO paralogselective modification has been shown to be
determinedat the levelofdeconjugation (Zhuetal. 2009). Itappearedprobable thatAR
SUMO2/3 conjugatesmight beprocessedmore rapidly than SUMO1modified formsof
AR.Inlinewiththisconcept,ARSUMOylationassayusingdeconjugationdefectiveforms




former being the major one. Mutation of these lysines to arginines (R) impairs AR
SUMOylation(Poukkaetal.2000a).Interestingly,promyelocyticleukemiaprotein(PML)is
modifiedbySUMOsatthreelysineresidues,whicharemodifiedbySUMO1orSUMO2/3
to different extents (Kamitani et al. 1998, Gong & Yeh 2006), suggesting that SUMO
acceptor sites may independently show a preference for different SUMO paralogs.







Figure 7. Disruption of the single SUMOylation lysine (K386R or K520R) in the AR shows similar 
SUMO paralog-selectivity as the wild-type (wt) receptor. COS-1 cells were cotransfected with 
expression vectors encoding wtAR, ARK386R or ARK520R with or without SUMO-1 or SUMO-2 
as indicated. After 40 h transfection, cells were treated with 100 nM testosterone for 2 h and 
lysed in denaturing SDS buffer containing N-ethylmaleimide (NEM, 10 mM). The cell extracts 






Thus far, no one has reported that anymodifiers other than SUMOswould target
K386and/orK520intheAR.However, thisremainsapotentialpossibility.Therefore, the
SUMOconsensusmotifs intheARweremutatedbyreplacingtheglutamate(E)residues
388 and 522 to alanine (A),whileK386 andK520 remained intact.As shown in Fig. 8A,
SUMOmodificationsof theE388,522Amutatedreceptorwere impairedsimilarlytothose
of the ARK386,520R (Poukka et al. 2000a). In addition, the E388,522Amutated AR was
significantly (p0.001) more active than wtAR (Fig. 8B), which is in line with the
ARK386,520R data of Poukka and coworkers (2000a). Importantly, KtoR mutations
preserve thenetchargeof the receptor,andadditionally, thesizeof theparticularamino
acidresidueisnotsignificantlyaltered.Incontrast,EtoAmutationsleadtoachangeboth
inthechargeandthelengthoftheaminoacidsidechain.Basedonresultsofthemutation






Figure 8. Mutation of the SUMOylation consensus motifs in the AR impairs receptor SUMOylation 
and enhances the AR transcriptional activity. A. COS-1 cells were cotransfected with expression 
vectors encoding wtAR or the E388,522A-mutated receptor with or without SUMO-1 or SUMO-2 
as indicated. After 40 h transfection, cells were treated with 100 nM testosterone for 2 h. The 
cell extracts were prepared and analyzed as described in Fig. 7. B. COS-1 cells were 
cotransfected with a pARE2-TATA-luc together with expression vectors encoding wtAR or 
ARE388,522A. One day after transfection, cells were incubated in the presence or absence of 
testosterone (T, 100 nM) for 18 h. LUC and -galactosidase (a control assessing for transfection 
efficiency) activities were measured. Relative LUC activity of wtAR in the presence of T is set as 
1 and the other values are in relation to that value. The columns represent the mean ± SD 
values of a representative experiment with triplicate samples. 
 
5.2   SIGNALS AFFECTING AR SUMOYLATION 
5.2.1Theroleofligandandsubcellularlocalization
Androgen binding induces a conformational change, nuclear translocation and
transcriptional activation of the AR. In addition, several PTMs, the smallmolecule




influence conjugation of SUMOs to theNTD of the receptor. Different AR ligandswere






VCaPcellsreflectingagonist inducedformationofARSUMOconjugates inPCcells (Fig.
1AII).
TheandrogenboundARisconcentratedintothenucleus.Itcouldbepostulatedthat
nuclear translocation is a premise for receptor SUMOylation.However, AR occupied by







expression of PIAS1 did not rescue the lack of ARLBD SUMOylation suggesting that
deletion of the LBD may disrupt interaction surfaces for SUMO E3 ligases. AR LBD
containstwohydrophobicsequences,713VxVV716and815IIxV818,thatmaybepossible





In addition to increased nuclear accumulation and SUMO modifications of the AR,
androgenscan inducephosphorylationof thereceptor (Kuiperetal.1991).Thehormone
induced kinetics of AR phosphorylation (Gioeli et al. 2002) are similar to that of
SUMOylation (Fig. 1B in I). Previously it has been demonstrated that phosphorylation
regulatesSUMOylationofheatshockfactor1(HSF1)andSTAT1(Hietakangasetal.2003,
Hietakangasetal. 2006,Vanhatupaetal. 2008).Theeffectof severalARphosphositeson




MAPK kinase 6 (MKK6E) impairedAR SUMOylation.However, this effectwas indirect
becausealso theextentofSUMOylationof thephosphorylationdeficientreceptormutant
ARS81,94,256,308,424A(AR5A)wasreduced(Fig.2AinI).Theseresultsdemonstratedfor
the first time that the sameARmolecule canbe concomitantlySUMOylatedatK386and
phosphorylatedatS650(Fig.2BinI).
Itwas also studiedwhether the acetylation sites in thehinge regionof the receptor
could regulate AR SUMOylation, since acetylation may orchestrate with SUMOylation
(Yang&Sharrocks2004).Pointmutationof the lysines630,632,and633 toargininesdid





the SUMOylation to occur. HDACs have been suggested to stimulate SUMOylation,
particularlytheconjugationofSUMO2(Gregoire&Yang2005,Zhaoetal.2005).HDAC4
hasbeenreportedtoenhancetheformationofARSUMO1conjugates(Yangetal.2011).In
the experimental conditions employed in this study, coexpression of HDAC4 did not
influence the formation of either ARSUMO1 or ARSUMO2 conjugates in COS1 cells
(datanotshown).Inconclusion,eventhoughacetylationsites intheARandHDAC4did









SUMOylated AR (Fig. 1A in I). SUMOylation has been also proposed to label cellular
proteins for ubiquitylation and degradation (Uzunova et al. 2007). Inhibition of
proteasomes could lead to stabilizationof SUMOconjugatedproteins, also theAR inPC
cells.AsshowninAppendixFig.A3inII,amassiveaccumulationofslowlymigratingAR
immunoreactive species was seen in VCaP cells treated with the proteasome inhibitor,
MG132.Furthermore,othertypeofproteasomeinhibitors,lactacystinandepoxomycin,had
the same effect (data not shown). The tested compounds belong to different classes of




of proteasome subunit 
5 over 
1 or 
2. However, they are not specific proteasome
inhibitors. For instance, MG132 is known as an inhibitor of calpain and other cysteine
proteases(Mooreetal.2008).Blockageoftheproteasomefunctionleadstoaccumulationof














the data with the SUMOylationdeficient AR indicated that ubiquitin is not likely to
conjugateatK386andK520,sinceARK386,520Rdisplayedincreasedubiquitylationrelative
tothatfoundwithwtAR.Inagreementwiththisconcept,ARK386,520Runderwentfaster
degradation than wtAR after addition of the protein synthesis inhibitor, cycloheximide
(CHX)(Fig.2BinII).TheARmutantcontainingadeletioninthehingeregionappearedto
beunabletoundergoinSUMOylation(Fig.2CinI).AsimilarARmutanthasbeenshown
to be more sensitive to proteasomemediated degradation than the wtAR (Tanner et al.
2004).Toconclude,SUMOylationdoesnotprimetheARfordegradation.
Stresstriggered proteinmodifications by SUMO2/3 have recently been reported to
occurindifferentcelltypes.Forexample,hypothermiahasbeenshowntoinducenuclear
accumulation of SUMO2/3 conjugates in neurons. This reversiblephenomenonhas been
postulated toactasanendogenousneuroprotectivestress response (Datwyleretal.2011,
Wang L. et al. 2012). In addition, cellular stress has been shown to induce SUMO2/3
modifications in testes (Shrivastavaetal.2010).ExcessiveSUMO2/3conjugationhasalso
been found in spermas amarker of defective spermatozoa (Vigodner et al. 2013). These




was studied only with ectopic SUMO1. Since it was found that cell stress enhanced
particularlyaccumulationoftheSUMO2/3modifiedARspecies,SUMO2modificationof
theAR5AmutantwascomparedtothatofthewtARintransfectedCOS1cells.However,










that belong to the family of cysteine proteases. Firstly, the isopeptidase activities of five
mammalianSENPsindeconjugatingdifferentSUMOparalogswereexamined(Fig.3AinI).
TheeffectsofSENPsweredemonstratedtobedependentonintactcatalyticdomainsofthe
enzymesbymutating the specific cysteine residues into serines. In linewith the findings
publishedbyotherresearchgroups(Gong&Yeh2006,Shenetal.2006),SENP1andSENP2
were potent in deconjugating both SUMO1 and SUMO2 from cellular proteins, while
SENP3 and SENP5 showed clear preference towards SUMO2conjugated proteins.
Secondly, the isopeptidase activity of the SENPs toward ARSUMO1 conjugates was
compared in intact cells and in vitro (Fig. 3B and C in I). Similar to total cellular




Stresstriggered AR SUMOylation was found to be reversible in VCaP cells, i.e.
alleviationofthestress ledtothedisappearanceofARmodifications.Whenheatstressed
cellsweretransferredbackto37°C,theARconjugateswerenolongerdetected(Fig.1Cin
II). The findings indicated that endogenous SUMOmodifications of theARaredynamic
and readily adjusted in response to changes in cellular environment. As discussed, the




accumulate in VCaP cells. An assay employing a hemagglutinintagged SUMO2
conjugatedtovinylsulfonebackbone(HASUMO2VS)wasperformed.Briefly,thisassay
is based on the ability of HASUMO2VS to covalently and specifically react with the
nucleophiliccysteineresiduewithintheactivesitesofcellularSENPs(explained indetail
in:Mukhopadhyay et al. 2006,WangY. et al. 2009). Vinyl sulfone reaction products are
detectedby immunoblottingwithanantiHAantibody.As shown inFig.9, the signalof
reaction products indicating SENP activities was weaker in heatstressed cells than in
control cells. The massive increase in AR SUMOylation evoked by cellular stress is not
likelysolelydueto inhibitionofSENPactivity,sinceARmodificationsbydeconjugation
deficientSUMO2(SUMO2P)werenot furtherenhanced in transfectedCOS1cellsupon
heatstress(datanotshown).TheremaybespecificdifferencesbetweenSENPactivitiesin
cell stress (Yan et al. 2010, Pinto et al. 2012). In addition, SUMO E1 activity has been
proposedtobemodulateduponheatshock(Truongetal.2012).ThestudybyTruongand
coworkers (2012) demonstrated that the SAE2 subunit is autoSUMOylatedunder normal
conditons,whichpreventsE1E2interactionandthetransferofSUMOfromE1toE2and
the overall SUMO conjugation to target proteins. Heat shock reduced SUMOylation of
SAE2leadingtoanincreaseinglobalSUMOylation.SUMOylationofSAE2wasproposed
asamechanismforstoringapopulationofE1thatcanbereadilyactivatedinresponseto












Figure 9. Heat stress inhibits SENPs in VCaP cells as studied by vinyl sulfone (VS) assay. The 
cells were exposed to 43°C for 1 h as indicated and lysed. Different amounts of lysates (+ and 
++ with 5-fold difference) were incubated with 5 μM final concentration of HA-SUMO-2-VS 
(Boston Biochemicals). After a 15-min incubation at 20°C the reactions were stopped and 
analyzed by immunoblotting with anti-HA antibody. 

5.3  REVERSIBLE SUMO MODIFICATIONS MODULATE 
TRANSCRIPTIONAL ACTIVITY OF THE AR 
AR signaling ismechanistically similar to that occurring in the other SRs. SUMOylation
consensus sites in the NTDs of SRs are well conserved, and many components of the
SUMOylationpathwayhavebeenidentifiedascoregulatorsofSRsignaling(Poukkaetal.
1999, Kotaja et al. 2000, AbdelHafiz & Horwitz 2012). It is likely that SUMOylation
functions as a common regulator of the SR activity. PIAS1 is themajor PIAS protein in
VCaP cells, and it is upregulated by androgens as assessed by analysis of mRNA
expression(AppendixFig.A5inII).EndogenousARandPIAS1interactinVCaPcells,and
PIAS1enhancesSUMOylationof theholoAR(unpublisheddata).Theactivatingeffectof
PIAS1 on ARregulated transcription is dependent on intact SUMOylation sites in the
receptor,aswellason theE3SUMOligatingandSUMOinteractingpropertiesofPIAS1.
An intact SUMOylation pathwaymay be important in themodulation ofARdependent
transcription,sinceoverexpressionofPIAS1andSENP1havebeenfoundinPC(Chenget
al.2006,Hoeferetal.2012).
The AR containing the single K386R mutation showed similar activity as
ARK386,520R(Poukkaetal.2000a),but theSUMOylationdeficientARshowedenhanced
activitycomparedtowtARonlyonapromotergenedrivenbymorethanoneAREs(Fig.5B
in I). These results suggest thatmultipleAR contactswithDNAaremore important for
transcriptionalinhibitionthanthepresenceofseveralSUMOmodifiedsitesinthereceptor.
SimilarresultshavebeenshownfortheGRthatcontainsaproteinmotifcalledthesynergy
controlmotif (IniguezLluhi& Pearce 2000, Tian et al. 2002). Interestingly, the particular
sequencefoundintheGRwasidentifiedatthesametimeasaSUMOconsensusmotif in
the AR (Poukka et al. 2000a). Thus, mutations in the SUMO consensus sites have been
initially shown by two independent studies to derepress the synergistic function of SR
homodimers binding to compound response elements. The synergism has been
demonstrated to depend on the nature of the response elemets: AR dimers binding to





SENP1andSENP2areefficientenzymes in theabilities todeconjugateSUMOylated
AR.Thus,theeffectofSENPsontheARregulatedtranscriptionwasstudied.Asshownin
Fig.5AinI,bothSENPsactivatedwtAR,whiletheeffectofSENPswasonlymodestonthe
transcriptional activity of the SUMOylationdeficient AR. In line with the SUMOylation
data, theactivityofARLBDwasnotaffectedbySENP1(Fig.5CinI).TheenhancedAR







Figure 10. SENP1 enhances the synergism of AR dimers only on canonical AREs. COS-1 cells 
were cotransfected with LUC reporter vectors containing either canonical IR3 AREs or selective 
DR3 AREs (Callewaert et al. 2004) together with the expression vectors encoding wtAR, 
ARK386,520R and SENP1 as indicated. One day after transfection, cells were grown in the 
presence or absence of testosterone (T, 100 nM) for 18 h. LUC and -galactosidase activities 
were measured. Relative LUC activity of wtAR in the presence of T and in the absence of SENP1 
on canonical AREs is set as 1 and the other values are in relation to that value. The columns 
represent the mean ± SD values of a representative experiment with triplicate samples. 


SENPs increased also the transcriptional activity of endogenous AR in LNCaP
prostate cancer cells (Fig. 6AD in I). Conversely, silencing of SENPs by specific siRNAs
(Fig.7AinI)attenuatedtheexpressionofendogenousARtargetgenesinLNCaPs(Fig.7B
DinI).TheeffectsofectopicallyexpressedSENP1andSENP2onARactivityinLNCaPs
differed in their magnitude depending on the reporter construct being examined. Both
SENP1andSENP2clearly inducedexpressionofareportergenedrivenbytwosynthetic
AREs (pARE2TATAluc),whereas theSENP1hadonlyamodestand theSENP2hadno
effect on a reporter gene harbouring a natural promoter of the rat probasin gene [pPB(
285/+32)luc](Fig.6BandDinI).EctopicSENPsshowedcelllinespecificfeaturesintheir
activities(cf.panelsAinFig.5andFig.6inI).
SENP1 has previously been postulated to enhance the AR activity through
deSUMOylationofHDAC1(Chengetal.2004).ThedatainoriginalarticleIindicatesthat
theSENP1enhancedARactivityisduetoSENP1sdirectcatalyticmodeofactiononAR.
TheHDAC inhibitor, TSA, activatedwtAR and a similar stimulationwas observedwith
ARK386,520R(Fig.5DinI).Inaddition,thecoexpressedSENP1stillenhancedtheactivity
of the wtAR but not that of the SUMOylationdeficient AR with TSA exposure. If the




HDAC1 deacetylase activity, administration of TSA would be predicted to block the







2004). In addition, the formation of repressive chromatin structure by the nucleosome
remodelingATPaseMi2andthehistonemethyltransferaseSETDB1hasbeenpostulated
to be involved in the inhibition of SUMOylated TFs (reviewed byOuyang&Gill 2009).
However, this is likelynottobethecaseinARdependent transcription.BothDAXXand
Mi2 inhibitedAR in reporter gene assays, but the inhibitionwas notdependent on the
SUMOylationoftheAR,whileSETDB1hadnoeffectonwtARorARK386,520R(datanot






SUMOylation sites do not inhibit DNA binding of the receptor as analyzed by different






loadingof theARonto the regulatory regionsof endogenousAR targetgenes inLNCaP
cells(Fig.7EGinI).However,SUMOylationisevidentlyinvolvedinthedynamicsofAR
chromatin interactions, since theholoARand components of the SUMOylationpathway
cooccupiedtheregulatoryregionsoftheARtargetgenesinVCaPcells(Fig.6inII).
In an attempt to study the action of wtAR and SUMOylationdeficient receptor in
chromatin lansdcape, isogenicHEK293cell linesstablyexpressingwtARorARK386,520R
wereutilized.Analysisof thesecell lines showed the receptorSUMOylationhada target
gene specific effect on AR chromatin loading and androgen induction of different AR
regulated genes (Fig. 7 in II). Importantly, SUMOylationdeficientARdid not invariably
displayhighertranscriptionalactivitythanwtARaswasthecaseintheassaysbasedonthe
reportergenes containing syntheticAREs.Themodulatory effectof SUMOylationon the






distinctly dependent on SUMOylation. For instance, genes shown to be sensitive to
SUMOylation of theNR familymember steroidogenic factor 1 (SF1)  includehedgehog
signalingpathways (Leeetal.2011).PRSUMOylationmodulates theexpressionofgenes
involved in proliferative and prosurvival signaling pathways (Knutson et al. 2012). It
remains unclear whether genes affecting cell growth could also be sensitive to





SUMOylation modulates cooperation of GATA1 with its coregulator friend of
GATA1(FOG1)inatargetgeneselectivemanner(Leeetal.2009).Thedifferencebetween
wtARandARK386,520Rintranscriptionmayarisefromthegenedependentvicinityofthe
other cellspecific TFs, such as FOXA1. FOXA1 is known to interact with the AR
contributingtotheexpressionofARregulatedgenes(Gaoetal.2003,Leeetal.2008).The













5.4  EFFECT OF CELL STRESS ON THE AR ACTIVITY 
As presented in this study, signals that affected AR SUMOylation modulated AR
activity.TheeffectofcellstressonARdependenttranscriptionwasalsoanalyzedinVCaP
cells.HeatstresssuppressedaccumulationofARtargetgenemRNAs(AppendixFig.A4in
II), and similarly to the formation of ARSUMO conjugates, the attenuation in mRNA
expressionwas restored at 37°C.ConsistentwithmRNAexpression, loading ofARonto
regulatoryregionsofARtargetgeneswasalteredinareversiblemannerbyheatshockas
assessed by quantitativeChIP (Fig. 5 in II). The accumulation of S100P mRNA showed
faster recovery after a 30min heat shock as compared to TMPRSS2 and SPOCK1. The
relativeamountofS100PmRNA inheatstressedVCaPs recoveredwithin 2hours to the
expressionlevelmeasuredinnonstressedcells(AppendixFig.A4inII).Theanalysisofthe
AR loading onto the regulatory region of S100P after heat shock was indicative of an
enhancedARoccupancyas compared to thatbefore the stress (Fig. 5 in II).Thatmaybe
associatedwiththeimportanceofS100Pforcancercellsurvivalandproliferation.Indeed,
overexpression ofS100P has beendescribed to promote tumorigenesis andmetastasis in
diverse cancer models including PC (Averboukh et al. 1996, Parkkila et al. 2008).
Intriguingly,expressionofS100PishighlysensitivetoARSUMOylation(Fig.7AinII).
Inadditiontoheatstress,alsotheprostaglandin,15dPGJ2inhibitedDNAbindingof
the AR both on nakedDNA and chromatin (Fig. 6B and C in III). Accordingly, the
expressionofARtargetgenemRNAswasattenuatedinVCaPs(Fig.3inIII)andinLNCaPs
(data not shown) by the prostaglandin. The function of the wtAR appeared to bemore
pronetoinhibitionby15dPGJ2thanARK386,520Rbothinthereportergeneassays(Fig.4
inIII)andontheendogenoustargetgenesinPC3prostatecancercells(Fig.5inIII).The
results suggest that SUMOylation can modulate the responsiveness of the AR to this
compound. In addition, heat stress altered ARchromatin interactions in a target gene
selectivemanner in thewtARandARK386,520RexpressingHEK293 cells (Fig. 7B in II).
Thenovel results indicate thatSUMOylationcanmodulateAR function in thechromatin
landscape, which has not been formerly reported, since previous studieswere based on
ectopicallyexpressedproteinsandreportergenescontainingsyntheticresponseelements.
Asdiscussed,alsootherfactorsbesidestheARintheARtranscriptionalcomplexare




proteinprotein interactions are altered. In addition to diverse PTMs, cell stress triggers
severalotherpathways,suchasheatshockresponse,sothatcellscanrespondtochangesin
theirmicroenvironment.Heat shock response isanordered stressresponsepathway that
activatesDNAbindingTFs,namedasheatshockfactors(HSFs),tocontroltheexpression
ofstressprotectiveproteins,suchasheatshockproteins(HSPs)thatfunctionasmolecular
chaperones (Richter et al. 2010). A typical feature of heat shock response is the drastic
repressionof general transcription and translationpathways. Instead, thegeneprograms
involved in acute cell survival are activated. HSPs function as chaperones also under
normalcellularconditions.Forexample,HSP90andHSP70bindtheapoARincytoplasm.
Molecular chaperones appear to be important factors throughout the lifespan of theAR,
since they also interact with the holoAR and mediate receptor cycling on/off target
chromatinduringtranscriptioncycles(Prescott&Coetzee2006).
Anonlethalheatdosehasbeendescribed to induce temporary resistance against a
subsequentlethalheatshock,i.e.thedevelopmentofthermotolerance,whichiscontributed
by elevated levels ofHSPs, includingHSP70 (Roti Roti et al. 1998,KimH.J. et al. 2007).
Intriguingly,mildheatstressinducedtheexpressionofHSP70inVCaPcells,butrepeated
heatstressbluntedtheformationofARSUMO2/3conjugates(unpublishedobservations).
HSPs are lysinerich proteins that lack SUMO consensusmotif, but contain hydrophobic
sequences of valine and isoleucine similar to motifs identified as SIMs. According to
proteomics analyses, HSP70 and HSP90 are, indeed, targets for SUMO2 conjugation
(Blomsteretal.2009,Ouyangetal.2009).MildstressenhancedlevelsofHSP70maybind
and reserve the SUMO moeities modulating  AR SUMOylation in VCaPs exposed to
repeatedstress.Thefindingssuggestthatstresstriggeredsystemofchaperoneproteinsand
SUMO2/3 conjugationmay cooperate inmodulatingARdependent transcription in PC
cells.
Original article III contains the novel observation that an electrophilic stressor
prostaglandin 15dPGJ2 can induce substratespecific SUMOylation. The prostaglandin
binds covalently and irreversibly to the cysteine residues in targetproteins (Kim&Surh
2006). Prostaglandin 15dPGJ2 bound also to AR and induced SUMO conjugation as
assessed in VCaP cells (Figs. 12 in III). Furthermore, 15dPGJ2 inhibited ARdependent
transcription (Fig. 3 in III). Receptor SUMOylation was likely to modulate AR
responsivenesstothecompound(Figs.45inIII).Inadditiontodisruptionofthereceptor
DNA binding (Fig. 6 in III), the inhibitionwas due to a defect in AR folding, since the
receptor N/C interaction was prevented by 15dPGJ2 (Fig. 7A in III). Prostaglandin was
likelytotargettheARLBD(Fig.7BDinIII).Bindingof15dPGJ2totheARdidnotprevent
ligandbinding,becausebicalutamideand15dPGJ2hadanadditiveeffectonARinhibition
in VCaP cells (Fig. 8 in III). These findings may represent new approaches for
pharmacologicalresearchtodesignmoderndrugstargetingtheARinPC.
Interestingly,arsenictrioxide,usedasadruginancientChinesemedicine,caninduce




interactionwith UBC9 and enhanced PML SUMOylation (Zhang et al. 2010). PIAS1 has
beenrecentlysuggestedtomediatearsenictriggeredSUMOylationofPML(Rabellinoetal.
2012).Theprostaglandin 15dPGJ2 increased interactionof endogenousARandPIAS1 in
VCaPcells,while italsodisplayedbindingtoSENPs(unpublishedobservations).Arsenic
has been shown to repress AR activity by inhibiting receptor N/C interaction and
recruitmentof theAR to targetgene enhancer inPC cells (Rosenblatt&Burnstein 2009).
Thus, arsenic and 15dPGJ2 may share similar properties in enhancing SUMOylation of















2002c) andHIPK3 (Moilanen et al. 1998a) also display granular nuclear distribution. AR
shows dynamic nuclear mobility (van Royen et al. 2009), which is likely to permit AR
coregulatorinteractions in specific nuclear substructures. Furthermore,AR SUMOylation
maybeinvolvedinregulatingthereceptor’sintranuclearmovements.
Theoverallcellulardistributionandthehormoneinducednucleartranslocationofthe
wtAR and ARK386,520R are similar as originally discussed by Poukka and coworkers
(Poukka et al. 2000a). The intranuclearmobility of thewtAR and SUMOylationdeficient
receptorwasmeasuredbyfluorescencerecoveryafterphotobleaching(FRAP)assays.Both









Figure 11. SUMOylation modulates the nuclear mobility of the AR in COS-1 cells. The cells 
grown on Ibidi 8-well chambers (Integrated BioDiagnostics) were transiently transfected with 
expression vectors encoding EGFP-AR or EGFP-ARK386,520R and treated with R1881 (R) or 
bicalutamide (B). FRAP analyses were performed using Zeiss LSM 700 Confocal Microscope with 
Zen software 2009. Bleach pulses were performed with maximal laser intensity in 2.8 μm × 
15.8 μm ROIs, and serial images were collected over 90 s period. Background fluorescence and 
general bleaching during acquisitions were measured and the fluorescence intensity in the ROI 
was normalized to these values. Fifty nuclei were analyzed to calculate average recovery times 
with standard error of mean (SEM). ***, p  0.001 for the difference between wtAR and  
ARK386,520R in the presence of androgen (R), *, p  0.05 for the difference between wtAR and 
ARK386,520R in the presence of antiandrogen (B). 
 





cytoplasm and inhibition of the expression of AR target genes (Gioeli et al. 2006).
Repression of AR activity by 15dPGJ2 was not attributable to the nuclear export of the
receptor in VCaP cells (Fig. 6A in III), suggesting that cell stress may influence the
intranuclear distribution of the holoAR. Endogenous holoAR and SUMO2/3 showed
increasedcolocalizationinnucleargranulesinheatstressedVCaPcells(Fig.3AinII).The
subnuclear structures corresponded to the PML bodies (Fig. 3A in II) that are in contact
withthenuclearmatrixandarerichincomponentsoftheSUMOylationpathway.
The nuclear matrix is biochemically defined as the residual nuclear structure that
remainsafterextractionofmostofthechromatinandallofthesolubleandlooselybound
components. The nuclear matrix consists of the nuclear lamina and the internal nuclear
network of subassemblies that are joined and come into contact with other nuclear









is the best knownnuclearmatrix attachment region (MAR)binding factor. SATB1 is not
onlyaTFbutitisalsoaglobalchromatinorganizer,actingasalinkerbetweenchromatin
andthenuclearmatrixterritories(Galandeetal.2007).SATB1isatargetforSUMOylation
and it interacts with PIAS1. Furthermore, SUMOylation of SATB1 is involved in the
subnuclearrelocalizationofthefactor(Tanetal.2008,Tanetal.2010).Thus,impairmentin
the SUMOylation system may evoke severe defects in the nuclear structure and
transcriptionalprocesses.
The AR is a mobile protein that shuttles between different cellular compartments.
Upon androgen exposure, the AR becomes enriched in the nucleus, where it further
distributes intodifferent subcompartments.  Inaccordance, cellular fractionationofVCaP
cells showed that the holoAR was enriched in the nuclear matrix fraction to a greater
extentthantheapoAR(Fig.3BinII).HeatstressinducedaccumulationofSUMOylatedAR
almostcompletelyintothenuclearmatrixcompartment,andthecompartmentalizationof







Figure 12. Osmotic stress induces a dynamic and reversible change in the nuclear distribution of 
the holo-AR as visualized by live cell imaging. EGFP-tagged AR was transiently expressed in 
COS-1 cells grown on Ibidi 8-well chambers (Integrated BioDiagnostics) and treated with 
androgen (R1881). The green fluorescence derived from the AR was visualized by confocal 
microscopy (Zeiss LSM 700) in a representative cell nucleus before stress, 15 min after 
exposure to osmotic stress (0.3 M NaCl added to growth medium), and 15 min after recovery 
from the stress (NaCl-containing medium aspirated and substituted with normal medium). The 




This study showed that both agonist binding and cell stress increased AR
SUMOylationthataffectedreceptorsolubility.Thus, theresults implythatchangesinthe




that the relative amount of wtAR was increased in the nuclear matrix upon androgen
exposure, while the level of ARK386,520R in the nuclear matrix was not influenced by
androgen (Fig. 3D in II).The findingsare in linewith themobilitydata inFRAPassays.
Heat stress resulted in increased accumulation of both receptor forms into the nuclear
matrix fraction. Interestingly, therelativeamountofARK386,520Rwasmorepronounced
thanthelevelsofwtARinthenuclearmatrixofheatstressedcells,bothintheabsenceand
presenceofandrogen(Fig.3DinII).Insummary,androgeninducedSUMOylationislikely
to modulate the intranuclear mobility and distribution of the AR, while stressforced








In agreementwith the concept that SUMOylationmay influence protein solubility,
the SUMOylationdefectivemutant of CREB binding protein (CBP) has been reported to
show reducedmobility compared to its wildtype counterpart (Ryan et al. 2010). Taken
together,theseresultsindicatethatSUMOylationcanregulatethemobilityofTFsandtheir
coregulatorsinthenucleoplasm.SUMOylationmayregulatetheresidencytimeofTFson









Figure 13. A schematic presentation of the dynamic AR movements in the nucleoplasm. The 
upper part of the figure shows a confocal image of prostate cancer cell nuclei, where green 
fluorescence depicts immunostained holo-AR.  A) Androgens induce AR nuclear translocation 
and SUMOylation. B) SUMOylated AR binds to chromatin, and is cycled on/off chromatin and the 
nuclear matrix during transcription cycles. C) Cell stress induces massive hyperSUMOylation of 
the AR, which prevents AR-chromatin interactions and induces accumulation of SUMOylated AR 
in the nuclear matrix. SUMOylation sustains AR solubility that enables receptor cycling. D) 
SUMOylation-defective AR is translocated into the nuclear matrix in an androgen-enhanced 
manner in cell stress. E) SUMOylation-defective AR is less soluble compared to the SUMO-
conjugated AR and it may be poorly cycled. Polyubiquitylation and proteasomal degradation of 






SUMO modifications are essential for the normal physiology of living organisms. An
exampleof the importanceof SUMOylation is thatdifferenthumanpathogens target the
host cell SUMOylation pathway to dampen the host response to infection (reviewed by
(Wimmer et al. 2012). Furthermore, dysfunctional SUMOylation pathway is linked to
development of neurogenerative diseases and tumorigenesis. This study aimed at
understanding the role of SUMO modifications in the regulation of ARdependent
transcription inPC cells.The resultsdiscussed in this thesishave important implications
withregardtobothARfunctionandPCbiology.Themainfindingsare:

 SUMOylation of the AR modulates androgenregulated gene expression in a










 SENPs, particularly SENP1, reverse the SUMO modifications of the AR and
modulateexpressionofARtargetgenes.

 Silencing of SENP1 retarded proliferation of androgentreated PC cells,
suggestingthatSUMOylationmayaffectcellsurvivalandproliferation.

This study provides new information about the role of SUMOmodifications in the
regulationofARtranscriptionalactivity.AndrogensenhancetheARSUMOylation.SUMO
conjugation stabilizes the AR, since SUMOylationdefective AR shows higher
ubiquitylationandfasterdecaythanSUMOylatedreceptor.DuetoSUMOylation,theARis
divided intodistinctsubpopulationswithinacell, i.e.poolsofARandARSUMO,which
display different properties in intranuclear kinetics and distribution.  The AR pools are
likely to be recruited onto the chromatin AREs of different genomic regions in a
SUMOylationmodulatedmanner.ARSUMOylationissuggestedtobeinvolvedinreceptor
cycling between chromatin and the nuclear matrix compartments during transcription
activity cycles. Therefore, intact nuclear structure that regulates chromatin arrangement
seemstobeimportantfortheexpressionofSUMOsensitiveARtargetgenes.
Modern genomewide DNAsequencing and gene expression technologies enable
analysisoftheARchromatinoccupancyandexpressionofandrogenregulatedgenes.Such
genomewidestudies inanimalmodelsystemswouldexpandthecurrentcomprehension
of the AR function and SUMOylation. In particular, analysis of tissues from knockin








PC samples between individuals displaying different grades of prostatic growth would
assist to discover novel PC markers. SENP1 has already been suggested as a potential
prognostic factor inPC (Li et al. 2012). In addition, the roleof SUMOylation indifferent
stages of carcinogenesis could be explored. Thus, medical intervention targeting the
SUMOylationsystemcouldbedirectedinanappropriatecancerphase,possiblyasafuture
therapy against cancerous cell growth. In conclusion, the results presented in this thesis
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Regulation of Androgen 
Receptor Signaling by 
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Regulation of Androgen Receptor 
Signaling by SUMO Modifications
in Prostate Cancer Cells
Androgen receptor (AR) is a pivotal 
transcription factor in the develop-
ment of prostate cancer. In addition 
to male sex hormones, also post-
translational modifications can affect 
AR function and thus regulate the 
expression of androgen-responsive 
genes. This study proves that re-
versible modifications by a small 
ubiquitin-like modifier (SUMO) are 
important in the regulation of AR 
function in prostate cancer cells. The 
results may provide novel prospects 
for targeting the AR in prostate can-
cer cells.
